K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

@article{Disclaimer2002KDOQICP,
  title={K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.},
  author={KDOQI Disclaimer},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2002},
  volume={39 2 Suppl 1},
  pages={S1-266}
}
  • KDOQI Disclaimer
  • Published 2002 in
    American journal of kidney diseases : the…
Increasing evidence, accrued in the past decades, indicates that the adverse outcomes of chronic kidney disease, such as kidney failure, cardiovascular disease, and premature death, can be prevented or delayed. Earlier stages of chronic kidney disease can be detected through laboratory testing. Treatment of earlier stages of chronic kidney disease is effective in slowing the progression toward kidney failure. Initiation of treatment for cardiovascular risk factors at earlier stages of chronic… CONTINUE READING
Highly Influential
This paper has highly influenced 33 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
2,904 Citations
356 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 2,904 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 356 references

African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial

  • Wright JT, S Xu
  • JAMA 285:2719–2728,
  • 2001

C reactive protein in patients with chronic renal diseases

  • V Panichi, M Migliori, S De Pietro
  • Ren Fail 23:551–562,
  • 2001

Similar Papers

Loading similar papers…